Found: 76
Select item for more details and to access through your institution.
Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of Age.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01040-8
- By:
- Publication type:
- Article
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01003-z
- By:
- Publication type:
- Article
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01024-8
- By:
- Publication type:
- Article
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01023-9
- By:
- Publication type:
- Article
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00950-3
- By:
- Publication type:
- Article
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00945-0
- By:
- Publication type:
- Article
Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exploring health behaviors and the feasibility of a lifestyle intervention for patients with multiple myeloma.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 12, p. 9771, doi. 10.1007/s00520-022-07385-9
- By:
- Publication type:
- Article
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-020-01164-y
- By:
- Publication type:
- Article
Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1429, doi. 10.1111/bjh.19326
- By:
- Publication type:
- Article
Chimeric antigen receptor and bispecific T‐cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 887, doi. 10.1111/bjh.19244
- By:
- Publication type:
- Article
Recommendations on prevention of infections during chimeric antigen receptor T‐cell and bispecific antibody therapy in multiple myeloma.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 736, doi. 10.1111/bjh.18909
- By:
- Publication type:
- Article
Reporting of race and ethnicity at an international haematology conference.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. e107, doi. 10.1111/bjh.17065
- By:
- Publication type:
- Article
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. 442, doi. 10.1111/bjh.16987
- By:
- Publication type:
- Article
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 816, doi. 10.1111/bjh.14170
- By:
- Publication type:
- Article
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 235, doi. 10.1111/bjh.14046
- By:
- Publication type:
- Article
Waldenström macroglobulinaemia: the key questions.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 3, p. 295, doi. 10.1111/bjh.12367
- By:
- Publication type:
- Article
Trends in the use of therapeutic plasma exchange in multiple myeloma.
- Published in:
- Journal of Clinical Apheresis, 2020, v. 35, n. 4, p. 307, doi. 10.1002/jca.21798
- By:
- Publication type:
- Article
An updated single center experience with plerixafor and granulocyte colony‐stimulating factor for stem cell mobilization in light chain amyloidosis.
- Published in:
- Journal of Clinical Apheresis, 2019, v. 34, n. 6, p. 686, doi. 10.1002/jca.21747
- By:
- Publication type:
- Article
Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 229, doi. 10.1002/ajh.26768
- By:
- Publication type:
- Article
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 140, doi. 10.1002/ajh.26596
- By:
- Publication type:
- Article
Corneal toxicity with belantamab mafodotin: Multi‐institutional real‐life experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E451, doi. 10.1002/ajh.26728
- By:
- Publication type:
- Article
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next‐generation sequencing in multiple myeloma treated with quadruplet therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1170, doi. 10.1002/ajh.26640
- By:
- Publication type:
- Article
Prevalence of Race/Ethnicity Reporting in Light Chain (AL) Amyloidosis Clinical Research in the USA.
- Published in:
- Journal of Racial & Ethnic Health Disparities, 2023, v. 10, n. 2, p. 644, doi. 10.1007/s40615-022-01252-3
- By:
- Publication type:
- Article
Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2238961, doi. 10.1001/jamanetworkopen.2022.38961
- By:
- Publication type:
- Article
Development and initial validation of the AL‐PROfile patient‐reported outcome measure in light chain (AL) amyloidosis.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 900, doi. 10.1111/ejh.14183
- By:
- Publication type:
- Article
Differences in patient‐reported outcomes (PROs) by disease severity in light chain (AL) amyloidosis.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 4, p. 536, doi. 10.1111/ejh.14036
- By:
- Publication type:
- Article
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (PROMs).
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 3, doi. 10.1111/ejh.13774
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy in Chronic Lymphocytic Leukemia: A Report of Three Cases and Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 1, p. E1, doi. 10.3816/CLML.2010.n.009
- By:
- Publication type:
- Article
A study to assess the psychosocial aspects of care for cancer patients with COVID-19 at Tata Memorial Hospital, Mumbai, India.
- Published in:
- Ecancermedicalscience, 2021, v. 15, n. 1316-1337, p. 1, doi. 10.3332/ecancer.2021.1330
- By:
- Publication type:
- Article
Low temperature studies of Bi doped Pr<sub>0.6</sub>Sr<sub>0.4</sub>MnO<sub>3</sub> manganites: magnetization and magneto-transport.
- Published in:
- Journal of Materials Science: Materials in Electronics, 2018, v. 29, n. 23, p. 19965, doi. 10.1007/s10854-018-0126-6
- By:
- Publication type:
- Article
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 7, p. e196476, doi. 10.1001/jamanetworkopen.2019.6476
- By:
- Publication type:
- Article
Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.667054
- By:
- Publication type:
- Article
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 863, doi. 10.1016/j.clml.2022.07.007
- By:
- Publication type:
- Article
P-152: Providing nutritional guidance for patients with plasma cell disorders – a missed opportunity for hematologists and oncologists?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S118, doi. 10.1016/S2152-2650(21)02279-5
- By:
- Publication type:
- Article
OAB-051: Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd), autologous transplantation and MRD response-adapted treatment duration and cessation in newly diagnosed Multiple Myeloma (NDMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S33, doi. 10.1016/S2152-2650(21)02125-X
- By:
- Publication type:
- Article
Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 10, p. e775, doi. 10.1016/j.clml.2021.06.004
- By:
- Publication type:
- Article
Monoclonal Gammopathies After Renal Transplantation: A Single-center Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Changes in cardiac biomarkers with daratumumab therapy in patients with light chain amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e321, doi. 10.1016/j.clml.2019.09.528
- By:
- Publication type:
- Article
Isatuximab short duration fixed volume infusion combination therapy for relapsed/refractory multiple myeloma (RRMM): phase 1b feasibility/safety study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e283, doi. 10.1016/j.clml.2019.09.466
- By:
- Publication type:
- Article
Relapse after allogeneic hematopoietic cell transplantation for multiple myeloma (MM): Single center experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e273, doi. 10.1016/j.clml.2019.09.450
- By:
- Publication type:
- Article
Progressive augmentation and long-term facilitation of ventilation is mitigated following a reduction in oxidative stress in individuals with obstructive sleep apnea.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A822, doi. 10.1096/fasebj.21.6.a822-d
- By:
- Publication type:
- Article
Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00681-x
- By:
- Publication type:
- Article
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00633-5
- By:
- Publication type:
- Article
Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study.
- Published in:
- 2022
- By:
- Publication type:
- Editorial